Evaluation of therapeutic effect and placebo effect of low level laser therapy in temporomandibular disorders

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180602039951N1

Enrollment

Registered

2019-09-15

Start date

2019-09-06

Completion date

Unknown

Last updated

2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

temporomandibular disorders. Temporomandibular joint disorders

Interventions

Intervention 1: Intervention group 1: gallium–aluminum–arsenide, 808nm ? 300 mw? 3J/cm2 ? 10S 10 session ( twice a week for 5 weeks), 4 points around temporomandibular joint and every muscle trigger

Eligibility

Sex/Gender

All

Age

15 Years to 60 Years

Inclusion criteria

Inclusion criteria: acute and chronic myofascial pain ( muscle trigger point) TMJ tenderness without degenerative diseases limitation of mouth opening due to muscle pain or TMJ inflammation ability of reading and writing to answer questionnaires patient cooperation and compliance men and women between 15-60 years old

Exclusion criteria

Exclusion criteria: using NSAID, corticosteroids,anti-convulsant, anti-psychotic, anti-depressant and narcotics mixed dentition developmental head and face deformity current orthodontic treatment, orthopedic appliance or splint therapy dental carries which replicated patient's pain in head and face partial or complete denture pregnancy and breast feeding history of pathological lesions in temporomandibular regions history of chemotherapy and radiotherapy of head and neck inability of answer to questionnaires periodontal diseases rheumatologic diseases Degenerative Joint Disease TMJ

Design outcomes

Primary

Measure	Time frame
Effect of low level leaser therapy on total trigger point score. Timepoint: Total trigger point score before intervention, and 1, 2, 3,4,5,weeks during intervention and one month after final intervention will be recorded. Method of measurement: head and neck muscles examination.;Effect of low level leaser therapy on jaw sounds. Timepoint: before intervention, and 1, 2, 3,4,5,weeks during intervention. Method of measurement: Stethoscope.;Effect of low level leaser therapy on jaw movement. Timepoint: before intervention, and 1, 2, 3,4,5,weeks during intervention. Method of measurement: ruler.;Effect of low level leaser therapy on visual analog scale. Timepoint: before intervention, and 1, 2, 3,4,5,weeks during intervention. Method of measurement: visual analog scale.	—

Measure

Time frame

Effect of low level leaser therapy on total trigger point score. Timepoint: Total trigger point score before intervention, and 1, 2, 3,4,5,weeks during intervention and one month after final intervention will be recorded. Method of measurement: head and neck muscles examination.;Effect of low level leaser therapy on jaw sounds. Timepoint: before intervention, and 1, 2, 3,4,5,weeks during intervention. Method of measurement: Stethoscope.;Effect of low level leaser therapy on jaw movement. Timepoint: before intervention, and 1, 2, 3,4,5,weeks during intervention. Method of measurement: ruler.;Effect of low level leaser therapy on visual analog scale. Timepoint: before intervention, and 1, 2, 3,4,5,weeks during intervention. Method of measurement: visual analog scale.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSahar Mafi

Kerman University of Medical Sciences

s.mafi@kmu.ac.ir+98 34 3211 9021

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026